Screener
ArriVent BioPharma, Inc. AVBP Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from ArriVent BioPharma, Inc.’s reported figures.
The source filing: ArriVent BioPharma, Inc.’s 10-Q, filed May 11, 2026. Open the filing →
- Filed
- May 11, 2026, 4:08 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-058650
FAQ
- What is ArriVent BioPharma, Inc.'s enterprise value?
- ArriVent BioPharma, Inc. (AVBP) reported enterprise value of $958.05M in Q1 2026.
- How has ArriVent BioPharma, Inc.'s enterprise value changed year-over-year?
- ArriVent BioPharma, Inc.'s enterprise value increased by 65.4% year-over-year, from $579.23M to $958.05M.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.
Ask your AI about ArriVent BioPharma, Inc.'s enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude